B1, a novel amonafide analogue, overcomes the resistance conferred by Bcl-2 in human promyelocytic leukemia HL60 cells

Molecular Cancer Research

Volumn 8, Issue 12, 2010, Pages 1619-1632

  Liang, Xin ^a   Xu, Yufang ^a   Xu, Ke ^a   Liu, Jianwen ^a   Qian, Xuhong ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMONAFIDE; ANTINEOPLASTIC AGENT; B1 (DRUG); BETA ACTIN; N [2 (DIMETHYLAMINO)ETHYL] 2 AMINOTHIAZONAPHTHALIMIDE; PROTEIN BAX; PROTEIN BCL 2; SMALL INTERFERING RNA; STRATIFIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL STRAIN HL 60; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CPG ISLAND; DOWN REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METHYLATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROMYELOCYTIC LEUKEMIA;

14-3-3 PROTEINS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZOTHIAZOLES; CELL LINE, TUMOR; DNA-BINDING PROTEINS; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; GENE KNOCKDOWN TECHNIQUES; GENES, BCL-2; GENES, MDR; GENES, P53; HL-60 CELLS; HUMANS; K562 CELLS; LEUKEMIA, PROMYELOCYTIC, ACUTE; NAPHTHALIMIDES; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING; U937 CELLS;

EID: 78650486142     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-10-0341     Document Type: Article

References (41)

1. Fisher DE. Apoptosis in cancer therapy: Crossing the threshold. Cell 1994;78:539-42.
2. Hickman JA. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 1992;11:121-39.
3. Cohen JJ. Apoptosis. Immunol Today 1993;14:126-30.
4. White E. Life, death, and the pursuit of apoptosis. Genes Dev 1996;10:1-15.
5. Williams GT, Smith CA. Molecular regulation of apoptosis: Genetic controls on cell death. Cell 1993;74:777-9.
6. Tsujimoto Y, Croce CM. Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 1986;83:5214-8.
7. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 1997;275:1132-6.
8. Dasmahapatra G, Almenara JA, Grant S. Flavopiridol and histone deacetylase inhibitors promote mitochondrial injury and cell death in human leukemia cells that overexpress Bcl-2. Mol Pharmacol 2006;69:288-98.
9. Yin XM, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 1994;369:321-3.
10. Yin DX, Schimke RT. BCL-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells. Cancer Res 1995;55:4922-8.
11. Park JW, Choi YJ, Suh SI, Baek WK, Suh MH, Jin IN, et al. Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis 2001;22: 1633-9.
12. CamposL,RouaultJP,SabidoO,OriolP,RoubiN,VasselonC,et al.High expression of bcl-2 protein in acutemyeloid leukemia cells is associated with poor response to chemotherapy. Blood 1993;81: 3091-6.
13. Lowenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med 1999;341:1051-62.
14. Smith M, Barnett M, Bassan R, Gatta G, Tondini C, Kern W. Adult acute myeloid leukaemia. Crit Rev Oncol Hematol 2004;50:197-222.
15. Qian XH, Li ZG, Yang Q. Highly efficient antitumor agents of heterocycles containing sulfur atom: Linear and angular thiazonaphthalimides against human lung cancer cell in vitro. Bioorg Med Chem 2000;15:6846-51.
16. Liang X, Wu AB, Xu YF, Xu K, Liu JW, Qian XH. B1, a novel naphthalimide- based DNA intercalator, induces cell cycle arrest and apoptosis in HeLa cells via p53 activation. Investig New Drugs 2010.[Epub ahead of print ].
17. Liu LJ, Yang F, Zhang Y, Li JL. Studies on the cell immunosuppressive mechanism of Oridonin from Isodon serra. Int Immunopharmacol 2007;7:945-54.
18. Verma M, Singh SK, Bhushan S, Sharma VK, Datt P, Kapahi BK, et al. In vitro cytotoxic potential of Polyalthia longifolia on human cancer cell lines and induction of apoptosis through mitochondrial-dependent pathway in HL-60 cells. Chem-Biol Interact 2008;171:45-56.
19. Levites Y, Youdim MBH, Maor G, Mandel S. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappa B (NF-kappa B) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol 2002;63:21-9.
20. Zhang J, Shen YL, Liu JW, Wei DZ. Antimetastatic effect of prodigiosin through inhibition of tumor invasion. Biochem Pharmacol 2005;69: 407-14.
21. Rho JH, Kang DY, Park KJ, Choi HJ, Lee HS, Yee SB, et al. Doxorubicin induces apoptosis with profile of large-scale DNA fragmentation and without DNA ladder in anaplastic thyroid carcinoma cells via histone hyperacetylation. Int J Oncol 2005;27:465-71.
22. Park SE, Kim ND, Yoo YH. Acetylcholinesterase plays a pivotal role in apoptosome formation. Cancer Res 2004;64:2652-5.
23. Sai MKP, Jasti SR. CpG island promoter methylation and silencing of 14-3-3s gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2. Oncogene 2006;25:4559-72.
24. Sharma D, Blum J, Yang X, Beaulieu N, Macleod AR, Davidson NE. Release ofmethylCpG binding proteins and histone deacetylase 1 from the estrogen receptor {alpha} (ER) promoter upon reactivation in ERnegative human breast cancer cells. Mol Endocrinol 2005;19:1740-51.
25. Wang J, Wu AB, Xu YF, Liu JW, Qian XH. M2-A induces apoptosis and G2-M arrest via inhibiting PI3 K/Akt pathway in HL60 cells. Cancer Lett 2009;283:193-202.
26. Zhu H, Huang M, Yang F, Chen Y, Miao ZH, Qian XH, et al. R16, a novel amonafide analogue, induces apoptosis and G2-M arrest via poisoning topoisomerase II. Mol Cancer Ther 2007;6:484-95.
27. Hermeking H. The 14-3-3 cancer connection. Nat Rev Cancer 2003;3:931-43.
28. Mhawech P. 14-3-3 proteins-an update. Cell Res 2005;15:228-36.
29. Subramanian RR, Masters SC, Zhang H, Fu H. Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis. Exp Cell Res 2001;271:142-51.
30. Tudor G, Aguilera A, Halverson DO, Laing ND, Sausville EA. Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels. Cell Death Differ 2000;7:574-86.
31. Ngan CY, Yamamoto H, Takagi A, Fujie Y, Takemasa I, Ikeda M, et al. Oxaliplatin induces mitotic catastrophe and apoptosis in esophageal cancer cells. Cancer Sci 2008;99:129-39.
32. Yee SB, Baek SJ, Park HT, Jeong SH, Jeong JH, Kim TH, et al. zVADfmk, unlike BocD-fmk, does not inhibit caspase-6 acting on 14-3-3/ Bad pathway in apoptosis of p815 mastocytoma cells. Exp Mol Med 2006;38:634-42.
33. Woo KJ, Yoo YH, Park JW, Kwon TK. Bcl-2 attenuates anticancer agents induced apoptosis by sustained activation of Akt/protein kinase B in U937 cells. Apoptosis 2005;10:1333-43.
34. Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H, et al. High frequency of hypermethylation at the 14-3-3s locus leads to gene silencing in breast cancer. Proc Natl Acad Sci U S A 2000;97:6049-54.
35. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: Epigenetics joins genetics. Trends Genet 2000;16:168-74.
36. Tate PH, Bird AP. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr Opin Genet Dev 1993;3:226-31.
37. Fujita N, Takebayashi S, Okumura K, Kudo S, Chiba T, Saya H, et al. Methylation-mediated transcriptional silencing in euchromatin by methyl-CpG binding protein MBD1 isoforms. Mol Cell Biol 1999;19:6415-26.
38. Nakagawachi T, Soejima H, Urano T, Zhao W, Higashimoto K, Satoh Y, et al. Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer. Oncogene 2003;22:8835-44.
39. Nguyen CT, Gonzales FA, Jones PA. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: Correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res 2001;29:4598-606.
40. Yu F, Thiesen J, Stratling WH. Histone deacetylase-independent transcriptional repression by methyl-CpG-binding protein 2. Nucleic Acids Res 2000;28:2201-6.
41. Ego T, Tanaka Y, Shimotohno K. Interaction of HTLV-1 Tax and methyl-CpG-binding domain 2 positively regulates the gene expression from the hypermethylated LTR. Oncogene 2005;24:1914-23.